Endogenous TAP-independent MHC-I antigen presentation: not just the ER lumen
- PMID: 31935516
- DOI: 10.1016/j.coi.2019.12.003
Endogenous TAP-independent MHC-I antigen presentation: not just the ER lumen
Abstract
Altered and infected cells are eliminated by CD8+ cytotoxic T lymphocytes. This requires production of antigenic peptides mostly in the cytosol, transport to the endoplasmic reticulum (ER) by the transporter associated with antigen processing (TAP), and cell surface presentation by major histocompatibility complex class I (MHC-I). Strikingly, antigen presentation occurs without TAP, although it is inefficient and associated to human pathology. TAP-independent peptides derive both from membrane and secreted proteins, as well as cytosolic ones. The efficiency of TAP-independent presentation may be impacted by the availability of receptive MHC-I, and in turn by the functional presence in the ER of the peptide-loading complex, itself anchored on TAP. Without TAP, surface expression of human leukocyte antigen (HLA)-B allotypes varies widely, with those presenting a broader peptide repertoire among the most TAP-independent. Much remains to be learned on the alternative cellular pathways for antigen presentation in the absence of TAP.
Copyright © 2019. Published by Elsevier Ltd.
Similar articles
-
Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER.Cancer Immunol Immunother. 2007 Aug;56(8):1143-52. doi: 10.1007/s00262-006-0263-2. Epub 2006 Dec 2. Cancer Immunol Immunother. 2007. PMID: 17143611 Free PMC article.
-
Spotlight on TAP and its vital role in antigen presentation and cross-presentation.Mol Immunol. 2022 Feb;142:105-119. doi: 10.1016/j.molimm.2021.12.013. Epub 2021 Dec 29. Mol Immunol. 2022. PMID: 34973498 Free PMC article. Review.
-
Assembly of tapasin-associated MHC class I in the absence of the transporter associated with antigen processing (TAP).Int Immunol. 2001 Jan;13(1):23-9. doi: 10.1093/intimm/13.1.23. Int Immunol. 2001. PMID: 11133831
-
Allele-dependent processing pathways generate the endogenous human leukocyte antigen (HLA) class I peptide repertoire in transporters associated with antigen processing (TAP)-deficient cells.J Biol Chem. 2011 Nov 4;286(44):38054-38059. doi: 10.1074/jbc.M111.281808. Epub 2011 Sep 13. J Biol Chem. 2011. PMID: 21914809 Free PMC article.
-
Peptide selection for presentation by HLA class I: a role for the human transporter associated with antigen processing?Immunol Res. 1996;15(4):265-79. doi: 10.1007/BF02935312. Immunol Res. 1996. PMID: 8988395 Review.
Cited by
-
Enrichment of Newly Synthesized Proteins following treatment of C2C12 Myotubes with Endotoxin and Interferon-γ.Inflammation. 2022 Jun;45(3):1313-1331. doi: 10.1007/s10753-022-01622-3. Epub 2022 Jan 14. Inflammation. 2022. PMID: 35028803 Free PMC article.
-
Viruses, cancer and non-self recognition.Open Biol. 2021 Mar;11(3):200348. doi: 10.1098/rsob.200348. Epub 2021 Mar 31. Open Biol. 2021. PMID: 33784856 Free PMC article. Review.
-
Variations in MHC class I antigen presentation and immunopeptidome selection pathways.F1000Res. 2020 Sep 28;9:F1000 Faculty Rev-1177. doi: 10.12688/f1000research.26935.1. eCollection 2020. F1000Res. 2020. PMID: 33014341 Free PMC article. Review.
-
PMN-MDSCs are responsible for immune suppression in anti-PD-1 treated TAP1 defective melanoma.Clin Transl Oncol. 2025 Jul;27(7):3073-3083. doi: 10.1007/s12094-024-03840-7. Epub 2025 Jan 18. Clin Transl Oncol. 2025. PMID: 39825997
-
Uncovering the Tumor Antigen Landscape: What to Know about the Discovery Process.Cancers (Basel). 2020 Jun 23;12(6):1660. doi: 10.3390/cancers12061660. Cancers (Basel). 2020. PMID: 32585818 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous